Improdia is an innovative, diagnostic company that is developing a simple blood test, that monitors the chronic inflammation level of patients suffering from autoimmune and cancer diseases, reflecting the Immune status of patients. Our novel blood-based test supports the diagnosis and management of chronic immune-mediated diseases. Through monitoring the immune status of cancer patients, Improdia’s … Continue reading About